Therefore, if the effects of proinflammatory cytokines, such as TNF-α, which are involved in the host’s immune response, could be slowly suppressed rather than completely blocked, then this could be applied to the treatment of rheumatoid arthritis and periodontitis, in which inflammatory bone destruction is the main pathology. The gene discussed is TNF; the disease is rheumatoid arthritis.